FDA orphan drug designation: treatment of polycythemia vera
All entries for: Vanda Pharmaceuticals Inc.
August 26, 2025
Vanda Pharmaceuticals Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of polycythemia vera